Acarbose
135 interactions 87 explained in plain English 266 cited referencesAcarbose is an alpha-glucosidase inhibitor used to help control blood sugar in type 2 diabetes. Read the full Acarbose drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Major
Acarbose Nifedipine Adalat® An increased risk of hyperglycemia and may lead to loss of glucose control Details Acarbose Norfloxacin Explained Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Acarbose Octreotide Acetate Explained An increased risk of hypoglycemia and impaired glucose regulation Details Acarbose Ofloxacin Floxin® Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Acarbose Pasireotide Diaspartate Explained An increased risk of hypoglycemia and impaired glucose regulation Details Acarbose Polythiazide Explained An increased risk of hyperglycemia and an increased insulin requirement Details Acarbose Pramlintide Symlin Explained An increased risk of hypoglycemia Details Acarbose Somatrogon-Ghla Explained Reduced insulin sensitivity Details Acarbose Sparfloxacin Explained Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Acarbose Thioctic Acid Explained Increased risk of hypoglycemia Details Acarbose Tolazamide Tolinase® Explained An increased risk of hypoglycemia Details Acarbose Tolbutamide Orinase® Explained An increased risk of hypoglycemia Details Acarbose Triamterene Dyrenium Explained An increased risk of hyperglycemia and an increased insulin requirement Details Acarbose Trovafloxacin Explained Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Acarbose Abiraterone Abirtega An increased risk of severe hypoglycemia Details Acarbose Delafloxacin Injection Baxdela Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Acarbose Furosemide Injection Disal An increased risk of hyperglycemia and an increased insulin requirement Details Acarbose Gatifloxacin Ophthalmic Zymar® Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Acarbose Insulin Degludec (Rdna Origin) Injection Ryzodeg® (as a combination product containing Insulin Degludec and Insulin Aspart) An increased risk of hypoglycemia Details Acarbose Insulin Detemir (Rdna Origin) Injection Levemir An increased risk of hypoglycemia Details Acarbose Insulin Glulisine (Rdna Origin) Injection Apidra An increased risk of hypoglycemia Details Acarbose Lanreotide Injection Somatuline An increased risk of hypoglycemia and impaired glucose regulation Details Acarbose Levofloxacin Injection Levaquin Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Acarbose Methotrexate Injection Abitrexate® Increased methotrexate exposure, an increased risk of methotrexate-related severe adverse reactions, reduced active metabolite for... Details Acarbose Moxifloxacin Injection Avelox Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Acarbose Moxifloxacin Ophthalmic Moxeza® Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Acarbose Octreotide Bynfezia An increased risk of hypoglycemia and impaired glucose regulation Details Acarbose Octreotide Injection Bynfezia An increased risk of hypoglycemia and impaired glucose regulation Details Acarbose Ofloxacin Ophthalmic Ocuflox Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Acarbose Ofloxacin Otic Floxin® Otic Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia DetailsModerate
Acarbose Lisinopril Prinivil Explained An increased risk of hypoglycemia Details Acarbose Acebutolol Sectral® Hypoglycemia or hyperglycemia; decreased symptoms of hypoglycemia Details Acarbose Activated Charcoal Explained Reduced effectiveness of acarbose Details Acarbose Amylase Explained Reduced effectiveness of acarbose Details Acarbose Aspirin Acuprin® Explained Increased risk of hypoglycemia Details Acarbose Atenolol Tenormin Explained Hypoglycemia or hyperglycemia; decreased symptoms of hypoglycemia Details Acarbose Benazepril Lotensin An increased risk of hypoglycemia Details Acarbose Betaxolol Betoptic S Hypoglycemia or hyperglycemia; decreased symptoms of hypoglycemia Details Acarbose Bisoprolol Zebeta® Hypoglycemia or hyperglycemia; decreased symptoms of hypoglycemia Details Acarbose Bitter Melon Explained Increased risk of hypoglycemia DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist